Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective pharmacogenetic analysis of lumiracoxib-associated severe liver enzyme elevation
2009-017148-15Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lumiracoxib, sponsored by Novartis. Primary endpoint: Presence or absence of DQA1*0102 allele. Started Apr 2010; status: completed.
02
Drugs
lumiracoxib
Beyond the preview
Go deeper on 2009-017148-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017148-15.